Press Release Nuvation Bio to Present New Subgroup Analyses of Pivotal Data for IBTROZI® (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses Aug 4
Press Release Nuvation Bio to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026 Jul 22